| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |